Back to Top
Go Back
Journal Photo for Ars Pharmaceutica
Peer reviewed only Open Access

Ars Pharmaceutica (ap)

Publisher : Faculty of Pharmacy of the University of Granada
Pharmaceutical Sciences Pharmacy Chemistry
Claim Your Journal Get PRC Visit Website
e-ISSN 2340-9894
Issue Frequency Quarterly
Est. Year 1960
Mobile 34958243921
DOI YES
Country Spain
Language English, Spanish
APC YES
Impact Factor Assignee Google Scholar
Email ars@ugr.es

Journal Descriptions

Ars Pharmaceutica is a multidisciplinary scientific journal, in the field of pharmaceutical sciences in its broadest sense, with special emphasis on Pharmaceutical Technology and Chemistry, Pharmacology, and Pharmaceutical Care. Edited by the Faculty of Pharmacy of the University of Granada since 1960 uninterruptedly. This magazine is the organ of expression of the Maria José Faus Dáder Chair of Pharmaceutical Care, since 2012. Its periodicity is quarterly (4 issues per year) and its standardized abbreviated name is Ars Pharm . It uses the system of external review by experts ( peer-review ), in the knowledge of the objects investigated and in the methodologies used in the investigations. The journal is aligned with the Open Access Journal and the articles that are published are published under the terms of the Creative Commons 4.0 International license ( CC BY-NC-SA 4.0 ) since 2018. Ars Pharmaceutical does not charge fees for the submission of works, nor for the publication of their articles.

Ars Pharmaceutica (ap) is :-

  • International, Peer-Reviewed, Open Access, Refereed, Pharmaceutical Sciences, Pharmacy, Chemistry, multidisciplinary , Online , Quarterly Journal

  • UGC Approved, ISSN Approved: P-ISSN E-ISSN: 2340-9894, Established: 1960,
  • Provides Crossref DOI

  • Indexed in: WoS, DOAJ

  • Not indexed in Scopus, PubMed, UGC CARE

Indexing

Publications of ap

Optimization of the gastroretentive system for controlled oral administration of cinnarizine using response surface methodology
Mehul Patel April, 2007
the gastroretentive administration of decynarizine. To produce controlled release floating cinnarizine tablets by direct compression, a Box-Behnken 33 design was used. The effects of formula...